GlassScriptPhysician profile
Bryan M Alford
NPI 1437578259
$2,691.77
in general payments reported to CMS, 2019-2025
22 companies · $886 in 2025
The $886 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $378 · 2023: $372 · 2024: $837 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,095.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $347.80 | 2021-2025 | Evenity |
| Biomerieux INC | $336.22 | 2025 | Filmarray Torch Module |
| Depuy Synthes Sales INC. | $255.09 | 2023-2025 | Tfn-Advance, Na, Va-Lcp |
| Atricure, INC. | $251.16 | 2023-2024 | |
| Bioventus LLC | $167.49 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Teva Pharmaceuticals USA, INC. | $138.03 | 2024 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $132.86 | 2024 | Fasenra |
| Boston Scientific Corporation | $129.60 | 2025 | Watchman Flx |
| Alexion Pharmaceuticals, INC. | $122.90 | 2024 | Ultomiris |
| Horizon Therapeutics Plc | $121.60 | 2023 | Uplizna |
| Abiomed | $114.12 | 2024 | Impella |
| Gilead Sciences, INC. | $98.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.57 | 2021 | |
| Shionogi INC | $92.59 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $78.47 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $71.90 | 2022 | |
| Peerless Surgical INC. | $46.80 | 2023 | |
| Noah Medical Corporation | $30.99 | 2023 | |
| Medela LLC | $17.51 | 2022 | |
| Solventum Corporation | $15.98 | 2025 | Prevena |
| Smith+Nephew, INC. | $15.94 | 2023 | Evos |
| Kci USA, INC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Alford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.